Language selection

Search

Patent 2130609 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2130609
(54) English Title: STABILIZED PEROXIDE GELS CONTAINING FLUORIDE
(54) French Title: GELS DE PEROXYDE STABILISES RENFERMANT UN FLUORURE
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 33/40 (2006.01)
  • A61K 8/21 (2006.01)
  • A61K 8/22 (2006.01)
  • A61K 8/27 (2006.01)
  • A61K 8/90 (2006.01)
  • A61Q 11/00 (2006.01)
(72) Inventors :
  • WILLIAMS, DAVID R. (United States of America)
  • RYLES, CHRISTINE W. (United States of America)
  • BARROW, STEPHEN R. (United States of America)
(73) Owners :
  • UNILEVER PLC
(71) Applicants :
  • UNILEVER PLC (United Kingdom)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1999-03-02
(22) Filed Date: 1994-08-22
(41) Open to Public Inspection: 1995-03-03
Examination requested: 1995-01-30
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
08/116092 (United States of America) 1993-09-02

Abstracts

English Abstract


An oral composition and method is provided that includes a peroxygen compound
such as hydrogen peroxide, a fluoride-containing anticaries agent and
a zinc compound such as zinc citrate. The presence of the zinc compound
inhibits decomposition that ordinarily would be induced by the presence of
fluoride.


French Abstract

Divulgation d'une méthode et d'une composition orale qui comprend un composé peroxygéné comme du peroxyde d'hydrogène, un agent de lutte contre la carie contenant du fluorure et un composé de zinc comme du citrate de zinc. La présence du composé de zinc inhibe la décomposition qui serait normalement provoquée par la présence de fluorure.

Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An oral dental product comprising:
a first composition comprising:
(i) from 0.1 to 10% by weight of a peroxygen compound;
(ii) a physiologically-acceptable fluoride-containing compound
present in an effective amount to inhibit formation of caries
on teeth; and
(iii) a zinc compound present in an effective amount to stabilize
the peroxygen compound against decomposition by the
fluoride-containing compound,
and a second composition comprising from 0.5 to 80% by weight of an
alkalimetal bicarbonate and a physiologically-acceptable
fluoride-containing compound present in an effective amount to inhibit
formation of caries on teeth, the first and the second composition
being held in a separate compartment of a dual-compartment
dispenser.
2. A dental product according to claim 1 wherein the fluoride anticaries
agent is sodium fluoride.
3. A dental product according to claim 2 wherein the sodium fluoride is
present in a concentration from 0.01 to 5% by weight.
4. A dental product according to claim 1 wherein the zinc compound is
zinc citrate.
5. A dental product according to claim 1 wherein the zinc compound is
present in an amount from 0.01 to 10% by weight.
6. A dental product according to claim 1 wherein the zinc compound is
present in an amount from 0.01 to 0.5% by weight.

7. A dental product according to claim 6 wherein the first composition
is a clear gel.

Description

Note: Descriptions are shown in the official language in which they were submitted.


2130609
I
ST~ 7Fn P~OXIDI~ CnNr~9/Nl~G
F~l/n~2E
~ACI~ OUNO OF 7~1~1NV~l~Q~Jf
The h~vanllon r~l~tes to dental products for proi-.uli.-~ health In the oral cavlty.
10 Orsl com~slllons contalnln~ both a p~fO. Id~ and wdlum blca.l~r~l~ have
boen acclalmod by th~ d~ntal pro~a~slon, e 5peci~11y throu~h the work of Keyes.
See Ke~e~ et al. ~rlcdoi)lk~ and Oral Hyghne~, .lanuary 1~78, p~ 51-56.
Formubtlons b~bod on the Keyes ~acl.riDlD~y, especlally the peroxlde
cG~,~pono.n~arepartlcul~tlypronotodoco~pos;lio.-. Thellteratureh ,pG.t~,d
15 conslder~ble research dlrectQd at the stability problem. For instance, see U.S.
Patent 3,577,~21 ~;ch~"Er), U.S. Pat~nt 4,837,008 ~Rudy et al), U.S. Patant
4,130,501 (L~), U.S. 4,89S,721 (~ruckerl ar~d U.5. Pstsnt 4,343,785
(Schmollca). A qulte sucGe s~ful approach to the pr~bl~ has Il~vol~Gd pi~sical
so~reçi~tlon of tne peroxld~ into a c~--,p~ t ~eparate from c~rea~ivo
~0 In~redlen~. U.S. Patcnt 4,849,213, U.S. Patent4,687,663 uld U.S. Pat~nt
4,528,180, all to Scl,aerfer, d~sclose a packa~e with a dual-con~a.l"h,.,t
re~pectlvel~/ storln~ a p~ xlde ~el and a blcal l,Gnate pa~te.
n~ J l~hnclu a~ Is Jesc.Il,ed In U.S. Patent4,487,757 ~Kio~r~cp'~u) whlch
25 ~1~ S ~ eb a toothpaste In a dlspenserthat physically sepuates sodium bic~rl.~
ate from acldic ;..~redlenls, e.~. citrlc or ascorbic~cids, to prevent contact
r~l~e~ prlor to us~e.
.,

2 2130609
In U.S. Patent 4,788.052. U.S. Patent 4,839,156 end U.S. P~tent 4,839,157
~all to N~ et ~I) are d~bc ,bed equeous hydro~en peroxide ~el ~ ~tir~lceo that
c~n be sbblllzed bV use of a combination of l~drophilllc and hydrophoblc furned
811ice. Aqueous moull)rinses have been described in U.S. P~tent 5,104,~44
5 ~Dou~b~ that contaln hydro~en per ~ dH. Al~o present ot relatlvely low
co,.~e.lt,~lh,..s ore such additives as zinc el,':riJe, s-J-r..~ rit, sodium cltrate
and cltrlc acld. It ~hould be noted that nelther the N~ et al nor Dou~las pd~
Include fluorlde anlons wlthln the su~ested c-l.nl ~,v;li-"-s.
10 From the af~.~..,eruicnGd att. it bece.ll~ 3ppa,ent that h~d-~a~n peroxlde
co..~>odlllol1~ should be formulated as simply as posslble ~o mlnlmlze polonll
Inte~lons between the pt;ru)~ e end the rem~lnlng In~sd's.-~s.
Fiuorldo anion 18 known by those skilled in the art as a de3l~b,111~1n~ faGtor in
15 porGI d~ ~els. The deslrablllty of acl.~ ntlcub4 proucllGn for oral
products h~ ro,..,~tl,d formul~ors to ~eek a s8tl5~ac~0ry means to ~llow
fluorlde Incorpo~llon. In U.S. Patent 5,037.633 and U.S. Patent 5,037,634
to Wllllams ot al. and Zlemklewlcz et al., resp~cli-/el~v, the problem was solved
by h~cofpor~tlno todlum fl~oride into a b'~.bon~le paste l~lt~,.,ded to be
20 co~xtruded ~rlth a pcroxlde ~el. each from a separate ~,n~ ,nl of a
dual~omp~rtment contalner. S~e also U.S. Patent 5,0~9,417 (Willl~ms et al.
dotallln~ the peroxlde l~chnn~y.
Whlls r~le~stln~ fluoride to the blcarbonate con~pone. ~I may solve the an-lco,ri~s
25 ,~.et'e..., there stlll remalns the problem of dlsp~nsin~ a co,-st~nt volum~ of
both pcr~ el end blcarbonate paste; accurate dosa~e of fluoride bas~d on
~otel ~nllrrloe volurne Is thereby ensured. Only wltl a speclal, costly pump 18
such pr~c:~e d~llver-,r ~chlevable.

J ~ 'Vl
Con~qu~ntly, ~ t~ ha~ been sou~ht whlch p~n~ both the blcarbonate
and the p6.0xlde co...pononts to each I~CGI~O~Ia sn id~rltlcal fluorld~
~.~tlCCrl6~ o~ent lhereb~ ellmlnatln~ need for a costl~ pump.
5 iBey~nd ~blll~tlon, any new anlicadas ~y~tem mu~ havs consumer
s~ti~l,ctory ta~e ~nd hsve no disruptive influcnce upon rl,~o!ooy, prociuctcoloror other physlc~ 1 PalLn~ al~-
n~c~nlly it has been rapo. laJ In U.S. Patent 5,217,710 ~Willi~ t ~1) th~t tin10 co.--~)ound~, e~p~ tanno.ls ion, may stabilke hydro~en p~roxlde In the
pt~s~nc~ of a f~uorlde compounci. Unfortunately, ther~ nre n~o problems wl~h
thk ~II~ID~. The first is thst stannous lons l~ rt sn un~atisfwtor~
m~alllc teste to the othe. lJJI~ fine or~anoleptic prope. L~s of the dont~l compo-
sltlon~. 5acon.1~r, the tln compound~ h~ve c~u~d sevcrc corroslve plttln~ of
1~ stainless ~toel ~~e~,t~r~ In which the dental pr~dw~ w~ m~nuf~ctured.
Accordingly, it is an object of the present invention to provide a peroxide-
containing composition capable of use with a bicarbonate composition
20 wherein both compositions contain a fluoride anticaries agent and there is
no adverse effect upon product stability. The peroxide composition and the
bicarbonate composition may be held in separate compartments of a dual-
compartment delivery system and each of the compositions may contain an
25identical fluoride anticaries agent.

4 ~ fi f~
The composition should have consumer-acceptable taste and maintain
color, e.g. blue.
Peroxide decomposition should be inhibited while still maintaining a clear
gel and the fluoride anticaries agent and stabilizing system should have no
adverse corrosive effect upon stainless steel manufacturing vessels.
SUMMARY OF THE INVENTION
An oral dental product comprising:
a first composition comprising:
(i) from 0.1 to 10% by weight of a peroxygen compound;
(ii) a physiologically-acceptable fluoride-containing compound
present in an effective amount to inhibit formation of caries
on teeth; and
(iii) a zinc compound present in an effective amount to stabilize
the peroxygen compound against decomposition by the
fluoride-containing compound,
and a second composition comprising from 0.5 to 80% by weight of an
alkalimetal bicarbonate and a physiologically~acceptable fluoride-
containing compound present in an effective amount to inhibit
formation of caries on teeth, the first and the second composition
being held in a separate compartment of a dual-compartment
dlspenser.
~ . ,~ I

J 61~ (V)
a~TAlLE~ /~SC~P7~nN
Now It ha~ been J~ red that zinc compounds hav~ the ~ AI e~t~d ablllt~
to Jtsblltze hl~d~ca~n peroxlde In tho pre~ence of a flwrldc co~pounq such
~odlum fluor~de.
Thw, as ~ first cssen~ wi"ponenl there is r~quired a cG,--pound, esi~ec~
~ salt, dellvo.l~.~ zlnc ions. B~ thc t~rm ~zinc lon" i8 meant that tbe zlnc-atom
portion of a ,n~le CLle of the zlnc compound in the solid or undisbcci~ted stato,
i5 cspnbb of bein~ dlssocl3ted into simple or complex zinc lons, especbll~
when . p~r~ed In an aqueous medium. Examples of the cG-,lpound~ th~t may
e~l ~n 71rc ~
/

~ u~u~ ~v~
213~9
c~. bo.)~t~, hexofruoroslllcate, ~,~.up~,o 6[1~1~tO, slllo~to, sulphate and tltlna~.
Or~nic anlons are thos~ havin~ from 2 to 22 carbon atoms wlth a cl~r~vJ
~roup selected from CL. l,o~-yl~t~, ~ulp~.v, l~t-" sulphate ar~ phospnate~ Specific
oxample~ Include, but ~re not llmited to, ac~lale, I,~n.c~al.J, citrste"Jly~ e,
5 lactate, pl ,~ Iphonate, salicylatc, tsrtrate, acetyld~"onat~., maleate,
succlnflt~, as~rl~ate, and ~luconate. Most prererreci is zinc citrste.
The zlnc salts wlll ~en~t~lly be pfCSe~ in the dental co,.,po~l~ion~ of the
lGn in ~n amount from ebout 0.01 tO about 10%, pre~r~bly between
10 about 0.1 and 5%, optlmally bel~r~rvo,, about 0.2 and 196 by wei~ht. When it
is deslrod to have e clear (at le~st tr~nslucen~) ~el, th~ level of zinc salt shouki
ran~e ~rom about 0.1 to 0.5%.
Another Impor~nt co~..pon~nl of the oral col"p~s'tio,- i~ th~t of a fluorlde
15 ~ntlc~rles cv-,.pound. Illu~t~ oS Sluorld~ compourKis are sodlum fluoride,
Jum tluorlde, calclum fluorlde, ...a~nes'u-n fluoride, stsnnous Ruoride,
~a.~)ous r~fl~Jorophosphal~, sodlum mo.~vnuoruphos~Jl.ate and copper
fluorldo. Thes~ ~ources should release an~Jher~, from about 25 to 3500 ppm
of fl~lorlde lon. The ~n~led~ O ~ent wlll b~ pre~ent in an arno-lnt from about
20 0.01 to ~bout S%, pr~fl~rably from about 0.1 to ~bout ~.596, optimall~y b~tw~en
about 0.2 and about 1.5% by wei~ht of the p~roxide coi,.rosl(lon.
A varlety of peroxy~en c~,-,pollnds may be employed including urea l,Gr~"-We,
calclum p~rox'~, h~l.o~en peroxlde and the s~lts of perl,o.atn, per~ilicate,
25 perlJho~pl.~.te and percsrbonate. Th~ most sultable for this inventlon is hydro-
~en p~lde. ~he emount of the peroxy~en compound may ran~e from about
û. 1 to about 1 og6 by weight. In terms ot active w~i~ht hydro~en peroxide, the
amount wlll r~n~e from about 0.5 to about 5%, pr~ferably from about 0.8 to

~ v lv~ ~l
213Q609
ebout 496, optin~lly benNeen sbout 1 ~nd 3% by wel~ht.
Oral compo~ltlons of the pr~senl l~,~.,ntlon may be In the fofm of elther a
toothpa~te, ~ ~el, a tablet, a p. ~:d~. or ~ mouthwash.
Water may b~ pre3em In the C0--1pGS;liOnS In amounts ran~in~ fronl about 20
to ebout 9596 by wei~ht, When the peroxide composition Is 8 ~el, the amount
of w~ter rn~y rsn~e from about 30 to about 55%, optlmally b~t~een about 35
and ~% by w~l~ht.
Structu~ants are ne&_ss~ where the peroxide C0-1-pQ~ Gn 1~; in the form of a
~1. Most sul~ble ~s the s~uctur~nt ~re the polyoxyethylene-polyoxypropylene
copoly.net~ whero the hydn,phe~l~ portlon, repr~sented by ~C~HoO), hs8 a
mobcubr wel~ht ren~ln~ from about 2,750 to 4,000 an~the hydrophllic
15 portlon, repre~emed by ~C211,0), c.u~lile~cs ~bout 70 to.~O% of the wol~ht of th~ CO~ y.l.3r. Commerclally the copoly"~ra are avallable from the BASF
Co~poratlon ~nderthe trad~ , Pluronlc F88, F99, F108 and ~127, Most
prato~l.,d l~ Pluronic F127 lI,~.eb,srt~r ,~r~.r~d to by Its CTF~ n~
Poloxomor 407~ whlch has a mslecu~r wel~ht ran~in~ from about 10,000 to
20 15,000, ~nd c~n~inln~ about 709~ of me hydrophillc polyoxyethylene mol~ty.
Amount8 oif the copoly."er can ran~e anywhere from 18 to 259~ by ~l~ht,
pref~r~bty b~_en 19 snd 24~6. Poloxamers are particularly sultable for this
l..~ron~lon LYce~Ee of th~ir wlde pH t ~ nc~, ~ood cGm~ ib;l;t~ with hydro~sn
pw~ ld~ end unlque ~el prop~ s.
Glyc~rol i8 cnother pr~ferred in~redient of the p~roxide composltion ~Ivhen in ~el
or rlnse form. Amounts of ~Iyoerol may ran~ from about 5 to about 60%,
pref~r~ly from sbout 5 tO 20% by wel~ht for t~ rinse snd from about 35 to

J 61 6~
8 ~ ~ 3 ~
45% by wel~ht for tho ~el.
Adlunct mlnor Ir,~,~dlonts msy elso be prc e.,l in the con~.p~sltlons of this
Ir.v~mlon. Included may be small amounts of colorant fbvor and z.~tloxldant.
Oral compositions of the present invention include besi~es a peroxide
co-nr ~lllv ~ on ~ddlllo-,al sepsrste bica~bon~ co,-l~ini--u com~oslllol~ each
held wlthln a ~ep~r~te container ~ tle for simultaneous d~ In
10 subs~ntlE~lly equal volumes for use In the mouth.
Th~ bicarbonate cG..,posillon wlll also contain a fluoride anticarles c~rs.pound~61e ~ed from the ~me fluorlde compounds in e~sentlally Identlc~l amounts to
those descrlbed h~r~. n~bove with respoct to the pe.uxtde cOI~ po~tlon.
15 E8peclally pr~r_r-~d iS sodium fluorid~. Bicalt~r~dt~. sa~ts will be pra~ent In
llmetal form ~xamplesof which are 80dlUlrl snd pot Yi Jm. Typlc~lly the
ConConlf~tlor, of blcsll,onet~ salt wlll ran~e from about 0.5 to about 8096,
preferably from ~bout 5 to about S096 optimally ba(~ n about 8 and ~bout
2096 by wel~lht of th~ total oombined dental product. The pH of the blcarbon-
20 ~te c~- Ir O ~liKion m~y r~n~e frorn about 7.0 to abo~n 9.5, most prefersoly about
8.0 to 9Ø When the blc~-~,onal~ col-,positlon 15 In tu~l,p~s~ or ~el ~orrn,
there wlll typlc~lly be includsd ~ n~tur~l or ;,~ tlc ll,lckel~ln~ a~ent In an
amount ~om about 0.1 to 10%, p-~f~ bly about 0.5 to 5~6 by wel~ht.
Thlcl~eners may include hydroxypropyl meth~l cellulose, hyd~oxyethyl cellulose,
25 sodlum c&.i-,,o~m~tl,~l cl~llulose, xanthan gum, ~ra~acanlh gum, karaya ~um,
~r~b~ ~um, Irlsh moss, st~rch, al~lna~es and car~a~eenans.
Su. 1~ 'C:tL. .ts tlre normally also included in Ihe bicarbon~te compositions. These
~.i, ,.. , . ~,~

J 6162 ~V)
2I3~6~3
surfactams may be of the anicnlc, nonionic, callon'C or ~,-,phot ic type. Most
preterred ere sodlum l~uryl sulfate, codium dode~ nLel~a SUIlOndl~ and
sodlum laurylsârcush~al~. Sulf~ d-lls are usually pr~e~l In an amount from
about 0.5 to nbout 5~6 by weight.
When In the form of a toothpaste or ~el, the bicarbonate co.r,p~sltions wlll
- norrn~lly Include an abraslve in a~d;t;on to the bica.t,on~le. Abraslves msy be
~ele t d ~rom water-lnsoluble alkall or ~Ik~llne earth me~l satt~ ot
met~pho~h~te nlVlP), c~lclum c~r~on~te, ~lumJn~te ~nd snlc~te. Especlsl~y
10 preferr~d ~re s~ dlce~cium phosph~tH ~nd calclum ce.bouet... Amounts of
the abraslve wlll range from about 5 to about 80% by wei~ht.
~rtsr control s~ents m~y be incorporated Into c~ Q6~0n~ of thl6 Ir-~ntlon.
Especlally effectlve wlll be ~ents contalnlng phosphorous. Inor~anlc
15 phosphorous t~rtar control s~ents may Include sodlllm trlpol~fphGs~hale ~r myof the wflter-soluble py.ophosphal~Osuch as disodium ~)~,u~Jl,o~phate, dlpot~s-
slum p~pl,a ;~h~te end mlxtures of these wlth telr~potanlllm
~,t..ph~sph~tos or tetra~odiurn p~.ophs sphat~s. Or~an-c phosphorous con~
pounds tinat may serve as tar~r control a~ents Include ~nly~h~sph~nat~s such
~0 ~s di~odlum ~lhan~ 1-hydroxy-1,1-diphosphonale (EHDP), ~n~ha,~Ji~ sphonk
acld, ~nd 2-phospt,o.~o~utane-1,2,~trica-boA~licacld.
Flavors are u8uelly pres e nt In both the p~roxido and, when sultable, blcal LonalG
c~n~po~l~lons These flavors rnay be based on olls of spearmlnt and
25 ptpper-,lint. ~x8r~plcs of ~ther flavorin~ ~na~ri~l~ include ~-,u,,ll-ol. clow,
wln~r~ .., eucalyptus and aniseed. Flavors may ran~e in conce"udliu.l from
about 0.1 to about 5% by wei~ht of the total composltlon.

J 6162 ~V~
,
2130609
.
.,v~ea~n' ~ n~ent~ such ~18 secchuin. sodlum ~ clo,-~le. aspe. l--...e, ~ucroso
and the llke may be includod at l~vels from about 0.1 to about 5% by wel~ht
of th~ tobl C~...,JO~I~IGI~.
5 Other oddltlves may also be IncG.,uGrOIed Into the or~l cG~IFQsltlons Includln~
~r.F~ tlves, 6111cones, other ~ ic or natural polymers such as G~ntrez
S-~7, and nntl~ln~lvltls actlves.
The ~ n:n~l ex~mples vvill more fully illustrate the embodlrnents of thls
10 Invenllon. All part~. percenla~es and proportions referred to hereln and In the
~ppended clalms a~e by wel~ht of the total ~o,n~,o~lliun unle~ v~ r-f~lse
~d.
E.~MPLE ~ ~
Typlcal of the pr~ent Invention i5 a peroxlde ~el w.,-p~sltlen whose
formulatlon k det8ihd under Table 1. 'rhe formulatlon of T~ble I may be Utlllz~dIn com,t l, .otlon wlm a blc~, bGnele co~npositiu" des~tled under Table IL each ot
20 tt-e c~n.~ ,n~ beln~ held in a ~epu~te CGIllp~ -,ent of a dual~"-~&. l--.ern
dl~penser.
~ .

J 61 62 (V~
,
11 21~6V9
...~ .
T~bk I
reroxlde Gel Con~. ~
1~4r. ~ P-r~l Wt.%
Pluron~c F127 20.000
8 ~'~yc~ 40,000
Hydl~Gr. Petoxide 13~% food ~rade) 4.285
Cltrlc Acld 0.~00
Sodlum Fluorlde 0.240
Zlnc Cltrate 0.200
FDJlC Blue 1 0.005
~ ~1 rh~rlc Acld ~85% w/w~ 0,150
D~lanl.~d water Babnce
Table n .
pic~r~o~Ate pACp Co-n~un~-lt
lr~ nt ~Wt.%
Polyol 11 (60r~JhGl and other su~srs) 48.710
Sylold ~3XX (~b~3~ . silica~ ~6.000
Sodlum E~lcL~ at~ 10.000
I'EG 32 (polyethylene ~lycol~ ~-000
Sylox 15x ~thlck~nln~ 8111ca) 4.600
Sodlum Lauryl Sulf~te 2.980
SD Alcohol 38B 2.850
Cellulo~e Gurn 0.800
M~ .tl.ol 0-500
Sodlum Sacch2rin 0.500
Sodium Fluorld~ 0.240
Tltanium Dloxlde ~' 0-300
D2'~ water Balance

J 6162 ~V~
12 2130
, _ ,
-
~AMae2
A ~erle~ of ~tablllty ax~,crlu.ents wer~ conducted to ov~luate the effect of ~Inc
citrate on s~bllizin~ a pe.oxTde ~el when fluorlde lon~ sre pr~se.-t in the
5 co...r ~filtion.
The test employed was the PeroAide Stablllty/Stress Test IPSST~ mple~
were ~ a~od to ~ccele.~led a~ln~ ~t a ~ -psr~ture ot 95-C over a ~hour
perlod. These a~in~ condlllGos were found to h~ve ~lood correl~ion ~th
10 3 o~cnt~ sto~e stablllty testin~ at 105~F. P~ra: 'da contont of the ~el w~
a~sayed by o-~hlkl~ ~sslum lodlde to lodlne snd tl~lslln,J wlth ~odlum
th'~sul~dl~ on ~n auto-titrator fltted Witll a redox ~l .,tl~de.
T~bb 11
1~ PSST Rewl~
Inl~bl % HZ02 After 6 llou~ ot 95~C
Recovery
NQ Fluorlde
1 Month at RT 1.48 1.36
91.88
1 Month ~t 105~F 1.47 1.34
91 .1 ~
F1uo~1de lO 74% t~) wlth Z~nc
251 Month ~t RT 1.46 1.46
1 00.00
Month at 106~F 1 .47 '1.43
.97
i
,
. . - - ,

J~1~2(V)
.
'~- 13 21~603
~orlde (0.~4% l~bFI Wl*lou~ Zlnc
1 da~ at RT 1.58 1.04
.42
3 days at RT 1.5~ 0.63
Table III p.uVIl~8~ stubi~ity results on the col..po~i~;on outllned in TAhh r c~f
Ex~mple 1 ~wlth and witho~Jt fluorlde~. From the resul~ It c~n be seen th~t ~Incc~ate h~ a st~lizin~ effoct upon the ~el co,.l~,o~;l;on In the pre~ence of
10 ffuoride ion. ~ca"enl % reco~,ery ot hydro~en pOf~: 'd~ 18 ~ d ~e~plte
stors~o ot tho formuls tT~ble I1 a~ 105~F for oi.len~sd poriods of tlnle.
The ~or~oln~ des~.lptlGn and Examples illustrate ~tle~ed embodln)en~s of the
pr~sent in~r~nllon. In ll~ht Il,ereof, varlous modlfl~l6n~ wlll be su~e~t~ to
15 one skllled In tl~ ~rt. ell of which are withln the splrl~ ~nd purvlew of thls
lu-.,nt-Q.~

Representative Drawing

Sorry, the representative drawing for patent document number 2130609 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2011-07-27
Inactive: First IPC derived 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 2004-08-23
Letter Sent 2003-08-22
Grant by Issuance 1999-03-02
Inactive: Final fee received 1998-11-12
Pre-grant 1998-11-12
Letter Sent 1998-06-01
Notice of Allowance is Issued 1998-06-01
Notice of Allowance is Issued 1998-06-01
Inactive: Application prosecuted on TS as of Log entry date 1998-05-27
Inactive: Status info is complete as of Log entry date 1998-05-27
Inactive: First IPC assigned 1998-05-04
Inactive: IPC removed 1998-05-04
Inactive: IPC assigned 1998-05-04
Inactive: Approved for allowance (AFA) 1998-04-30
Application Published (Open to Public Inspection) 1995-03-03
All Requirements for Examination Determined Compliant 1995-01-30
Request for Examination Requirements Determined Compliant 1995-01-30

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 1998-07-15

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 3rd anniv.) - standard 03 1997-08-22 1997-07-15
MF (application, 4th anniv.) - standard 04 1998-08-24 1998-07-15
Final fee - standard 1998-11-12
MF (patent, 5th anniv.) - standard 1999-08-23 1999-07-12
MF (patent, 6th anniv.) - standard 2000-08-22 2000-07-12
MF (patent, 7th anniv.) - standard 2001-08-22 2001-07-11
MF (patent, 8th anniv.) - standard 2002-08-22 2002-08-02
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
UNILEVER PLC
Past Owners on Record
CHRISTINE W. RYLES
DAVID R. WILLIAMS
STEPHEN R. BARROW
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 1998-04-08 13 400
Claims 1998-04-08 2 41
Cover Page 1999-02-23 1 27
Cover Page 1995-06-07 1 24
Description 1995-06-07 13 434
Abstract 1995-06-07 1 12
Claims 1995-06-07 3 49
Commissioner's Notice - Application Found Allowable 1998-06-01 1 164
Maintenance Fee Notice 2003-09-22 1 173
Correspondence 1998-11-12 1 47
Fees 1996-07-15 1 35
Prosecution correspondence 1994-08-22 10 326
Prosecution correspondence 1995-06-22 6 292
Prosecution correspondence 1995-06-22 1 45
Correspondence related to formalities 1997-10-07 1 38
Courtesy - Office Letter 1995-02-20 1 51
Prosecution correspondence 1998-02-25 2 74
Examiner Requisition 1997-08-26 2 45
Prosecution correspondence 1995-01-30 1 44
Courtesy - Office Letter 1994-11-07 1 44